And while people are using them as treatments, peptides aren't often described as drugs
These products are not subject to the same pharmaceutical manufacturing standards, sterility testing, or third-party verification that a licensed 503A compounding pharmacy must meet
Eur J Pharmacol 332: 2333
Dosage typically ranges from 200400mcg per administration
The GLOW Protocol typically features a compounded peptide formulation containing: GHK-Cu 10 mg BPC-157 3 mg TB-500 3.75 mg per mL This protocol is typically used as part of a 30-day regimen , though treatment recommendations may vary depending on the patient, goals, and provider guidance
AN: Data curation, Investigation, Methodology, Writing original draft